| HOME >> MEDICINE >> TECHNOLOGY |
5.21 Cardiac Markers Market, Australia, Revenue ($m), Historic, 2003 – 2010 39
5.22 Cardiac Markers Market, Australia, Revenue ($m), Forecast, 2010 – 2017 40
5.23 Cardiac Markers Market, Brazil, Revenue ($m), Historic, 2003-2010 41
5.24 Cardiac Markers Market, Brazil, Revenue ($m), Forecast, 2010 – 2017 42
6 Cardiac Markers Market: Strategic Competitive Assessment 43
6.1 Cardiac Markers Market, Global, Company Share (%), 2010 43
6.2 Cardiac Markers Market, Competitive Analysis 44
6.2.1 Threat of Rivalry 44
6.2.2 Threat of New Entrants 45
6.2.3 Buyer Power 45
6.2.4 Threat of Substitute 45
6.2.5 Supplier Power 45
6.3 Cardiac Markers: Key Market Participants 46
6.3.1 F. Hoffmann-La Roche Ltd. 46
6.3.2 Abbott Laboratories 48
6.3.3 Siemens Healthcare 50
6.3.4 Alere 53
6.3.5 Beckman Coulter, Inc. 55
7 Key Marketed Cardiac Markers 58
7.1 TROP T Sensitive Rapid Assay 58
7.1.1 Product Description 58
7.1.2 Features and Benefits 58
7.2 Cobas c 111 Analyzer 58
7.2.1 Product Description 58
7.2.2 Features and Benefits 58
7.3 I-STAT System 59
7.3.1 Product Description 59
7.3.2 Features and Benefits 59
7.4 Stratus CS Analyzer 59
7.4.1 Product Description 59
7.4.2 Features and Benefits 59
7.5 TriageBNP 60
7.5.1 Product Description 60
7.5.2 Features and Benefits 60
8 Cardiac Markers Market: Strategic Pipeline Assessment 61
8.1 Device Pipeline Products Summary 61
8.2 Profiles of Promising Products Under Clinical Development 65
8.2.1 VASCLIR 65
8.2.2 ARCHITECT MPO ASSAY 66
8.2.3 CADPrint 67
8.2.4 Presage ST2 Assay 68
8.2.5 Verigene Cardiac Troponin I Assay 69
8.2.6 Lab-on-a -Film Cardiac Sensor S
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |